Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Kahan

Showing results (1-10 of 167) with videos related to

Pageof 17
Sort By:
European Cardiology|October 13, 2018
Guest Editorial Challenges in Resistant HypertensionThomas Kahan
Blood Pressure|October 28, 2017
The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril StudyAndreas Jekell, Thomas Kahan
Pharmacoeconomics|October 29, 2017
Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in EuropeJonas Hermansson, Thomas Kahan
Lakartidningen|June 29, 2020
[Hypertension, RAAS blockade and risk in COVID-19 patients]Jonas Spaak, Thomas Kahan
Blood Pressure|May 1, 2010
Cardiovascular risk factors are not treated to target in hypertensive patients in primary careIngegerd Nieburg, Thomas Kahan
The European Journal of General Practice|October 25, 2014
A management programme for suspected heart failure in primary care in cooperation with specialists in cardiologyMärit Mejhert, Thomas Kahan
Microcirculation (New York, N.Y. : 1994)|December 22, 2021
Skin microvascular reactivity and subendocardial viability ratio in relation to dyslipidemia and signs of insulin resistance in non-diabetic hypertensive patientsAndreas Jekell, Majid Kalani, Thomas Kahan
Heart and Vessels|September 24, 2018
The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin-ramipril studyAndreas Jekell, Majid Kalani, Thomas Kahan
Journal of Clinical Hypertension (Greenwich, Conn.)|December 9, 2017
Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidityFredrik Wallentin, Björn Wettermark, Thomas Kahan
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 12, 2004
Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agentMiguel Quintana, Thomas Kahan, Paul Hjemdahl
Pageof 17

Showing results (1-10 of 167) with videos related to

Sort By:
Pageof 17
European Cardiology|October 13, 2018
Guest Editorial Challenges in Resistant HypertensionThomas Kahan
Blood Pressure|October 28, 2017
The usefulness of a single arm cuff oscillometric method (Arteriograph) to assess changes in central aortic blood pressure and arterial stiffness by antihypertensive treatment: results from the Doxazosin-Ramipril StudyAndreas Jekell, Thomas Kahan
Pharmacoeconomics|October 29, 2017
Systematic Review of Validity Assessments of Framingham Risk Score Results in Health Economic Modelling of Lipid-Modifying Therapies in EuropeJonas Hermansson, Thomas Kahan
Lakartidningen|June 29, 2020
[Hypertension, RAAS blockade and risk in COVID-19 patients]Jonas Spaak, Thomas Kahan
Blood Pressure|May 1, 2010
Cardiovascular risk factors are not treated to target in hypertensive patients in primary careIngegerd Nieburg, Thomas Kahan
The European Journal of General Practice|October 25, 2014
A management programme for suspected heart failure in primary care in cooperation with specialists in cardiologyMärit Mejhert, Thomas Kahan
Microcirculation (New York, N.Y. : 1994)|December 22, 2021
Skin microvascular reactivity and subendocardial viability ratio in relation to dyslipidemia and signs of insulin resistance in non-diabetic hypertensive patientsAndreas Jekell, Majid Kalani, Thomas Kahan
Heart and Vessels|September 24, 2018
The interrelation of endothelial function and microvascular reactivity in different vascular beds, and risk assessment in hypertension: results from the Doxazosin-ramipril studyAndreas Jekell, Majid Kalani, Thomas Kahan
Journal of Clinical Hypertension (Greenwich, Conn.)|December 9, 2017
Drug treatment of hypertension in Sweden in relation to sex, age, and comorbidityFredrik Wallentin, Björn Wettermark, Thomas Kahan
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|May 12, 2004
Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agentMiguel Quintana, Thomas Kahan, Paul Hjemdahl
Pageof 17